Researchers at the National Institute of Neurological Disorders and Stroke are studying Parkinson’s disease. The purpose of this research study is to determine if the experimental drug JP-1730 compared to a placebo (a sugar pill that neither helps nor harms) will help control both the symptoms of Parkinson’s disease and the complications of long-term treatment. The study lasts approximately 5 weeks and involves a short inpatient stay each week.

You may qualify if:

·        You are 30 -80 years of age

·        You are experiencing abnormal involuntary movements (dyskinesias)

·        You are finding your standard medications to be less effective than before

  

 You may not qualify if:

·        You have heart or lung disease.

·        You are pregnant or breast feeding.

 

    

 Location:

·        NIH Clinical Center in Bethesda, Maryland.

 Cost:

·        No cost for participation.

 

For more information:

1-800-411-1222

1-866-411-1010 (TTY)

Refer to study number: 02-N- 0236

  

For more information, please call:

1-800-411-1222

TTY 866-411-1010

Refer to study number 02-N-0236

Se Habla Español

 

Internet: www.cc.nih.gov

E-Mail: prpl@cc.nih.gov

This study is conducted under safety and testing standards of the Department of Health and Human Services.